Flavanoids and limonoids derived from citrus help to improve glucose tolerance and modulate cholesterol levels.
Type-2 diabetes is among a number of chronic diseases for which the incidence of onset is modifiable, with poor dietary factors contributing to increased risk. A Canadian research team has found that daily supplementation of citrus-derived flavanoids and limonoids may reduce risk factors for diabetes. In a pilot study with human subjects, these citrus compounds were shown to reduce glucose intolerance, cut total cholesterol by 13%, and slash LDL cholesterol by 23%. The researchers observe that: “This study demonstrated an important future role for [citrus-derived flavanoids and limonoids] in glycemic control and management of risk factors in subjects with [impaired fasting glucose].”
